Download PDF
Horm Metab Res 2009; 41(4): 281-286
DOI: 10.1055/s-0028-1102914
Original Basic

© Georg Thieme Verlag KG Stuttgart · New York

Visfatin Stimulates Production of Monocyte Chemotactic Protein-1 and Interleukin-6 in Human Vein Umbilical Endothelial Cells

S. W. Liu 1 , S. B. Qiao 1 , J. S. Yuan 1 , D. Q. Liu 2
  • 1Department of Cardiology, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • 2Department of Central Laboratory, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Further Information

Publication History

received 01.07.2008

accepted 14.10.2008

Publication Date:
13 November 2008 (online)

Also available at
    Permissions and Reprints

Abstract

Monocyte chemotactic protein-1 and interleukin-6 are important inflammatory cytokines, which have close relationships with atherosclerosis. Visfatin is a novel adipokine involved in regulation of inflammatory cytokines, however, associations of visfatin with cytokines (MCP-1, IL-6) in human umbilical vein endothelial cells are unclear. The aim of this study was to determine whether visfatin has effects on the expression of MCP-1 and IL-6 in human umbilical vein endothelial cells. Enzyme-linked immunosorbent assay were used for measuring MCP-1 and IL-6 production in human umbilical vein endothelial cells. Real-time quantitative reverse-transcription polymerase chain reaction was used for determining MCP-1 and IL-6 mRNA expression. For the pathway determination following inhibitors were used: wortmannin [phosphatiylinositol 3-kinase (PI3K)], SB203580 [p38 mitogen-activated protein kinase (MAPK)], PD98059 [extracellular signal-regulated kinase (ERK) 1/2)], JNK inhibitor II [c-Jun NH 2-terminal kinase (JNK)]. We demonstrated that visfatin could obviously upregulate secretion of MCP-1and IL-6 in a dose- and time-dependent manner in human umbilical vein endothelial cells. Visfatin-induced effects were diminished by SB203580, wortmannin, and PD98059. In summary, these results suggest that visfatin-induced MCP-1 and IL-6 production involve p38 MAPK, PI3K, and ERK 1/2 pathways in human umbilical vein endothelial cells as determined by inhibition with specific inhibitors.

Key words

visfatin - monocyte chemotactic protein-1 - interleukin-6 - human vein umbilical endothelial cells

References

  • 1 Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, Fukushima J, Kawamoto S, Ishigatsubo Y, Okubo T. NF-kB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene.  J Immunol. 1994;  153 2052-2063
    PubMedGoogle Scholar
  • 2 Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis.  Thromb Haemost. 2007;  97 714-721
    PubMedGoogle Scholar
  • 3 Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: from basic science to medicine.  Arthritis Res. 2002;  3 S233-S242
    PubMedGoogle Scholar
  • 4 Lotz M. Interleukin-6.  Cancer Invest. 1993;  11 732-742
    CrossrefPubMedGoogle Scholar
  • 5 Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?.  Atherosclerosis. 2002;  148 209-214
    PubMedGoogle Scholar
  • 6 Eckel RH, York DA, Rössner S, Hubbard V, Caterson I, St Jeor ST, Hayman LL, Mullis RM, Blair SN. American Heart Association. Prevention conference VII: obesity, a worldwide epidemic related to heart disease and stroke: executive summary.  Circulation. 2004;  110 2968-2975
    CrossrefPubMedGoogle Scholar
  • 7 Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion.  J Clin Endocrinol Metab. 2007;  92 1023-1033
    CrossrefPubMedGoogle Scholar
  • 8 Yudkin JS. Inflammation, obesity, and the metabolic syndrome.  Horm Metab Res. 2007;  39 707-709
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity- linked insulin resistance.  Science. 1993;  259 87-91
    CrossrefPubMedGoogle Scholar
  • 10 Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans.  Endocrinology. 2004;  145 2273-2282
    CrossrefPubMedGoogle Scholar
  • 11 Shimomura I, Funahashi T, Takahashi M, Maeda K, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity.  Nat Med. 1996;  2 800-803
    CrossrefPubMedGoogle Scholar
  • 12 Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals.  Nature. 1998;  395 763-770
    CrossrefPubMedGoogle Scholar
  • 13 Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1).  Biochem Biophys Res Commun. 1996;  221 286-289
    CrossrefPubMedGoogle Scholar
  • 14 Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes.  J Biol Chem. 1995;  270 26746-26749
    CrossrefPubMedGoogle Scholar
  • 15 Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes.  Nature. 2001;  409 307-312
    CrossrefPubMedGoogle Scholar
  • 16 Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinology of adipose tissue – an update.  Horm Metab Res. 2007;  39 314-321
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Samal B, Sun Y, Stearns G, Xie C, Suggs S, MacNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.  Mol Cell Biol. 1994;  14 1431-1437
    CrossrefPubMedGoogle Scholar
  • 18 Hammarstedt A, Pihlajamäki J, Rotter Sopasakis V, Gogg S, Jansson PA, Laakso M, Smith U. Visfatin is an adipokine, but it is not regulated by thiazolidinediones.  J Clin Endocrinol Metab. 2006;  91 1181-1184
    CrossrefPubMedGoogle Scholar
  • 19 MacGlothlin JR, Gao L, Lavoie T, Simon BA, Easley RB, Ma SF, Rumala BB, Garcia JG, Ye SQ. Molecular cloning and characterization of canine pre-B-cell colony-enhancing factor.  Biochem Genet. 2005;  43 127-141
    CrossrefPubMedGoogle Scholar
  • 20 Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, Tilg H. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.  J Immunol. 2007;  178 1748-1758
    CrossrefPubMedGoogle Scholar
  • 21 Luk T, Malam Z, Marshall JC. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity.  J Leukoc Biol. 2008;  83 804-816
    CrossrefPubMedGoogle Scholar
  • 22 Adya R, Tan BK, Punn A, Chen J, Randeva HS. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.  Cardiovasc Res. 2008;  78 356-365
    CrossrefPubMedGoogle Scholar
  • 23 Kim SR, Bae SK, Choi KS, Park SY, Jun HO, Lee JY, Jang HO, Yun I, Yoon KH, Kim YJ, Yoo MA, Kim KW, Bae MK. Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2.  Biochem Biophys Res Commun. 2007;  357 150-156
    CrossrefPubMedGoogle Scholar
  • 24 Adya R, Tan BK, Chen J, Randeva HS. 2008 Nuclear factor {kappa}B induction by visfatin in human vascular endothelial cells: role in MMP-2/9 production and activation.  Diabetes Care. 2008;  31 758-760
    CrossrefPubMedGoogle Scholar
  • 25 Kim SR, Bae YH, Bae SK, Choi KS, Yoon KH, Koo TH, Jang HO, Yun I, Kim KW, Kwon YG, Yoo MA, Bae MK. Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells.  Biochim Biophys Acta. 2008;  1783 886-895
    PubMedGoogle Scholar
  • 26 Tsiotra PC, Tsigos C, Yfanti E, Anastasiou E, Vikentiou M, Psarra K, Papasteriades C, Raptis SA. Visfatin, TNF-alpha and IL-6 mRNA expression is increased inmononuclear cells from type 2 diabetic women.  Horm Metab Res. 2007;  39 758-763
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Kase H, Hattori Y, Jojima T, Okayasu T, Tomizawa A, Suzuki K, Banba N, Monden T, Satoh H, Akimoto K, Kasai K. Globular adiponectin induces adhesion molecule expression through the sphingosine kinase pathway in vascular endothelial cells.  Life Sci. 2007;  81 939-943
    CrossrefPubMedGoogle Scholar
  • 28 Ajuwon KM, Spurlock ME. Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes.  Am J Physiol Regul Integr Comp Physiol. 2005;  288 R1220-R1225
    CrossrefPubMedGoogle Scholar
  • 29 Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction.  Circulation. 2003;  108 736-740
    CrossrefPubMedGoogle Scholar
  • 30 Libby P. Changing concepts of atherosclerosis.  J Intern Med. 2001;  247 349-358
    PubMedGoogle Scholar
  • 31 Weber C, Schober A, Zernecke A. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease.  Arterioscler Thromb Vasc Biol. 2004;  24 1997-2008
    CrossrefPubMedGoogle Scholar
  • 32 Brentano F, Schorr O, Ospelt C, Stanczyk J, Gay RE, Gay S, Kyburz D. Pre-B cell colony-enhancing factor/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities.  Arthritis Rheum. 2007;  56 2829-2839
    CrossrefPubMedGoogle Scholar
  • 33 Samara A, Pfister M, Marie B, Visvikis-Siest S. Visfatin, low-grade inflammation and BMI.  Clin Endocrinol (Oxf). 2008;  69 568-574
    CrossrefPubMedGoogle Scholar
  • 34 Goebeler M, Gillitzer R, Kilian K, Utzel K, Bröcker EB, Rapp UR, Ludwig S. Multiple signaling pathways regulate NF-kB-dependent transcription of the monocyte chemoattractant protein-1 gene in primary endothelial cells.  Blood. 2001;  97 46-55
    CrossrefPubMedGoogle Scholar
  • 35 Takaishi H, Taniguchi T, Takahashi A, Ishikawa Y, Yokoyama M. High glucose accelerates MCP-1 production via p38 MAPK in vas-cular endothelial cells.  Biochem Biophys Res Commun. 2003;  305 122-128
    CrossrefPubMedGoogle Scholar
  • 36 Dragomir E, Tircol M, Manduteanu I, Voinea M, Simionescu M. Aspirin and PPAR-a activators inhibit MCP-1 expression induced by high glucose concentration in human endothelial cells.  Vascul Pharmacol. 2006;  44 440-449
    CrossrefPubMedGoogle Scholar
  • 37 Choi EK, Park HJ, Ma JS, Lee HC, Kang HC, Kim BG, Kang IC. LY294002 inhibits monocyte chemoattractant protein-1 expression through a phosphatidylinositol 3-kinase-independent mechanism.  FEBS Lett. 2004;  559 141-144
    CrossrefPubMedGoogle Scholar
  • 38 Shibata T, Imaizumi T, Tamo W, Matsumiya T, Kumagai M, Cui XF, Yoshida H, Takaya S, Fukuda I, Satoh K. Cardiotrophin-1 stimulates intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human aortic endothelial cells.  Am J Physiol Heart Circ Physiol. 2008;  294 H750-H763
    PubMedGoogle Scholar
  • 39 Gomaraschi M, Basilico N, Sisto F, Taramelli D, Eligini S, Colli S, Sirtori CR, Franceschini G, Calabresi L. High-density lipoproteins attenuate interleukin-6 production in endothelial cells exposed to pro-inflammatory stimuli.  Biochim Biophys Acta. 2005;  1736 136-143
    PubMedGoogle Scholar
  • 40 Isoda K, Young JL, Zirlik A, MacFarlane LA, Tsuboi N, Gerdes N, Schönbeck U, Libby P. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.  Arterioscler Thromb Vasc Biol. 2006;  269 611-617
    PubMedGoogle Scholar
  • 41 Shibata T, Imaizumi T, Tamo W, Matsumiya T, Kumagai M, Cui XF, Yoshida H, Takaya S, Fukuda I, Satoh K. Proteasome inhibitor MG-132 enhances the expression of interleukin-6 in human umbilical vein endothelial cells: Involvement of MAP/ERK kinase.  Immunol Cell Biol. 2002;  80 226-230
    CrossrefPubMedGoogle Scholar

Correspondence

Prof. S. B. QiaoMD 

Department of Cardiology

Cardiovascular Institute and Fuwai Hospital

Chinese Academy of Medical Sciences and Peking Union Medical College

167 BeiLiShi Rd

100037 Beijing

China

Phone: 86/10/8839 88 62

Fax: 86/10/8839 88 62

Email: qiaosb@live.cn

      >